Now showing items 31-40 of 477
Syndrome X: Is it for real?
(Wiley Subscription Services, Inc., A Wiley Company, 1998)
The term syndrome X has been applied to the association of hypertension, non-insulin-dependent diabetes mellitus (NIDDM), android obesity, insulin resistance, and dyslipidemia. In this paper, based on population samples ...
A Method of Limited Replication for the Efficient In Vivo Delivery of Adenovirus to Cancer Cells
(Mary Ann Liebert, Inc., publishers, 1998-05-20)
Overview summary Replication-defective viral vectors are limited in their ability to diffuse through tissue. This poses a problem for treating tumors in vivo using gene transfer. This article demonstrates that limited ...
Hormone Resistance in Prostate Cancer
(Kluwer Academic Publishers; Springer Science+Business Media, 1998-12)
Effects of calyculin A on amylase release in streptolysin-O permeabilized acinar cells
(Elsevier, 1992-12-30)
The effects of the phosphatase inhibitors calyculin A and okadaic acid on amylase release from streptolysin-O permeabilized rat pancreatic acini were investigated. Both agents induced similar biphasic effects with moderate ...
Relation between impedance and endocardial contact during radiofrequency catheter ablation
(Elsevier, 1994-08)
Lesion size during radiofrequency catheter ablation in patients with paroxysmal supraventricular tachycardia (PSVT) is thought to be related to multiple factors, including contact pressure at the catheter-endocardial ...
On Replacing Peer Review with Legal Challenge in Scientific Research: An Opinion
(Blackwell Publishing Ltd, 1994-03)
Interactions of intracellular mediators of amylase secretion in permeabilized pancreatic acini
(Elsevier, 1991-01-23)
Mouse pancreatic acini were permeabilized with streptolysin O to investigate amylase secretion stimulated by various intracellular mediators and the kinetics of secretion as a function of temperature. Amylase secretion was ...
Studies on morpholinosphingolipids: Potent inhibitors of glucosylceramide synthase
(Elsevier, 1994-04-25)
Synthetic 1-morpholino-1-deoxyceramides were designed to inhibit glucosylceramide synthase. The most potent inhibitor 2a possesses the unnatural R,R-configuration of D-threo-sphingosine.